Clinical Trial Update: Stop Exogenous Allergic Alveolitis (EAA) in Childhood [Phase 2]

View source ↗

Summary

The Phase 2 pediatric trial aiming to stop Exogenous Allergic Alveolitis (hypersensitivity pneumonitis) was terminated, with results posted on December 18, 2024…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypersensitivity Pneumonitis

Snippet

Sponsor: Matthias Griese | Conditions: Hypersensitivity Pneumonitis, Exogenous Allergic Alveolitis | Phase 2 | Status: TERMINATED | Results posted: 2024-12-18